These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8646679

  • 1. S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome.
    Huuhtanen RL, Blomqvist CP, Wiklund TA, Virolainen MJ, Elomaa AI, Pan Y, Tribukait B.
    Cancer; 1996 May 01; 77(9):1815-22. PubMed ID: 8646679
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas.
    Pisters PW, Pollock RE, Lewis VO, Yasko AW, Cormier JN, Respondek PM, Feig BW, Hunt KK, Lin PP, Zagars G, Wei C, Ballo MT.
    Ann Surg; 2007 Oct 01; 246(4):675-81; discussion 681-2. PubMed ID: 17893504
    [Abstract] [Full Text] [Related]

  • 3. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
    Salas S, Stoeckle E, Collin F, Bui B, Terrier P, Guillou L, Trassard M, Ranchere-Vince D, Gregoire F, Coindre JM.
    Eur J Cancer; 2009 Aug 01; 45(12):2091-102. PubMed ID: 19351580
    [Abstract] [Full Text] [Related]

  • 4. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns.
    Michels JJ, Marnay J, Plancoulaine B, Chasle J.
    Cytometry B Clin Cytom; 2004 May 01; 59(1):32-9. PubMed ID: 15108168
    [Abstract] [Full Text] [Related]

  • 5. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P, Genestie C, Rey A, Morice P, Roche B, Lhommé C, Haie-Meder C, Duvillard P.
    Cancer; 2000 Mar 15; 88(6):1425-31. PubMed ID: 10717626
    [Abstract] [Full Text] [Related]

  • 6. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE, Cabeçadas J, Nóbrega SD, Mendonça E.
    Diagn Cytopathol; 2003 Oct 15; 29(4):194-9. PubMed ID: 14506670
    [Abstract] [Full Text] [Related]

  • 7. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B, Pizem J, Bracko M, Cufer T, Borstnar S, Pohar-Marinsek Z, Us-Krasovec M.
    Cytopathology; 2008 Oct 15; 19(5):294-302. PubMed ID: 18070112
    [Abstract] [Full Text] [Related]

  • 8. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients.
    Dreinhöfer KE, Baldetorp B, Akerman M, Fernö M, Rydholm A, Gustafson P.
    Cytometry; 2002 Feb 15; 50(1):19-24. PubMed ID: 11857594
    [Abstract] [Full Text] [Related]

  • 9. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A, Masetti R, Breccia C, Coppola R, Magistrelli P, Nuzzo G, Maggiano N, Picciocchi A.
    Hepatogastroenterology; 1999 Feb 15; 46(26):1187-91. PubMed ID: 10370689
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of S-phase fraction in head and neck squamous cell carcinomas and nodal negative breast carcinomas.
    Fietkau R, Iro H, Tulusan AH, Dressel V, Altendorf-Hofmann A, Sauer R.
    Strahlenther Onkol; 1994 Jan 15; 170(1):13-24. PubMed ID: 8303573
    [Abstract] [Full Text] [Related]

  • 11. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Breast Cancer Res Treat; 2005 May 15; 91(1):61-71. PubMed ID: 15868432
    [Abstract] [Full Text] [Related]

  • 12. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, Androulakis GA.
    J Surg Oncol; 2003 Apr 15; 82(4):247-55. PubMed ID: 12672009
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.
    Hasegawa T, Yamamoto S, Yokoyama R, Umeda T, Matsuno Y, Hirohashi S.
    Cancer; 2002 Aug 15; 95(4):843-51. PubMed ID: 12209729
    [Abstract] [Full Text] [Related]

  • 14. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V, Sørensen FB, Bentzen SM, Ladekarl M, Nielsen OS, Keller J, Jensen OM.
    Histopathology; 1998 Jun 15; 32(6):536-46. PubMed ID: 9675593
    [Abstract] [Full Text] [Related]

  • 15. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
    Massi D, Beltrami G, Capanna R, Franchi A.
    Eur J Surg Oncol; 2004 Dec 15; 30(10):1131-6. PubMed ID: 15522563
    [Abstract] [Full Text] [Related]

  • 16. [Results of radiotherapy in recurrences of soft tissue sarcomas].
    Schwarz R, Krüll A, Baumann M, Zornig C, Wiegel T, Weh HJ.
    Strahlenther Onkol; 1996 Feb 15; 172(2):64-73. PubMed ID: 8669047
    [Abstract] [Full Text] [Related]

  • 17. Management of soft tissue sarcomas (STS) in first isolated local recurrence: a retrospective study of 83 cases.
    Moureau-Zabotto L, Thomas L, Bui BN, Chevreau C, Stockle E, Martel P, Bonneviale P, Marques B, Coindre JM, Kantor G, Matsuda T, Delannes M.
    Radiother Oncol; 2004 Dec 15; 73(3):313-9. PubMed ID: 15588876
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
    Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL.
    Cancer; 2003 May 15; 97(10):2530-43. PubMed ID: 12733153
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma.
    Huuhtanen RL, Blomqvist CP, Wiklund TA, Böhling TO, Virolainen MJ, Tukiainen EJ, Tribukait B, Andersson LC.
    Br J Cancer; 1999 Feb 15; 79(5-6):945-51. PubMed ID: 10070895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.